Linking molecular classification of hepatocellular carcinoma and personalized medicine: Preliminary steps

Augusto Villanueva; Sara Toffanin; Josep M. Llovet

doi:10.1097/CCO.0b013e328302c9e9

Linking molecular classification of hepatocellular carcinoma and personalized medicine: Preliminary steps

Augusto Villanueva, Sara Toffanin, Josep M. Llovet

Research output: Contribution to journal › Review article › peer-review

70 Scopus citations

Abstract

Selection of patient candidates according to their tumor molecular background is a reality in human malignancies. Thus, a molecular classification is essential to allow the development of new targets, and to customize therapies in patients with hepatocellular carcinoma.

Original language	English
Pages (from-to)	444-453
Number of pages	10
Journal	Current Opinion in Oncology
Volume	20
Issue number	4
DOIs	https://doi.org/10.1097/CCO.0b013e328302c9e9
State	Published - Jul 2008

Keywords

Molecular classification
Molecular targeted therapies
Personalized medicine
Sorafenib

Access to Document

10.1097/CCO.0b013e328302c9e9

Cite this

@article{a9121f3c65214b3f912142fd089fcf79,

title = "Linking molecular classification of hepatocellular carcinoma and personalized medicine: Preliminary steps",

abstract = "Selection of patient candidates according to their tumor molecular background is a reality in human malignancies. Thus, a molecular classification is essential to allow the development of new targets, and to customize therapies in patients with hepatocellular carcinoma.",

keywords = "Molecular classification, Molecular targeted therapies, Personalized medicine, Sorafenib",

author = "Augusto Villanueva and Sara Toffanin and Llovet, {Josep M.}",

year = "2008",

month = jul,

doi = "10.1097/CCO.0b013e328302c9e9",

language = "English",

volume = "20",

pages = "444--453",

journal = "Current Opinion in Oncology",

issn = "1040-8746",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

TY - JOUR

T1 - Linking molecular classification of hepatocellular carcinoma and personalized medicine

T2 - Preliminary steps

AU - Villanueva, Augusto

AU - Toffanin, Sara

AU - Llovet, Josep M.

PY - 2008/7

Y1 - 2008/7

N2 - Selection of patient candidates according to their tumor molecular background is a reality in human malignancies. Thus, a molecular classification is essential to allow the development of new targets, and to customize therapies in patients with hepatocellular carcinoma.

AB - Selection of patient candidates according to their tumor molecular background is a reality in human malignancies. Thus, a molecular classification is essential to allow the development of new targets, and to customize therapies in patients with hepatocellular carcinoma.

KW - Molecular classification

KW - Molecular targeted therapies

KW - Personalized medicine

KW - Sorafenib

UR - http://www.scopus.com/inward/record.url?scp=47249104773&partnerID=8YFLogxK

U2 - 10.1097/CCO.0b013e328302c9e9

DO - 10.1097/CCO.0b013e328302c9e9

M3 - Review article

C2 - 18525342

AN - SCOPUS:47249104773

SN - 1040-8746

VL - 20

SP - 444

EP - 453

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

IS - 4

ER -

Linking molecular classification of hepatocellular carcinoma and personalized medicine: Preliminary steps

Abstract

Keywords

Access to Document

Fingerprint

Cite this